Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
Heart Podcast
00:00
Introduction
A detailed discussion on the history and mechanism of SGLT2 inhibitors, focusing on their effects on various cardiovascular diseases including blood glucose levels, weight, and blood pressure. The conversation reveals the initial focus of these drugs on kidney studies rather than diabetes treatment.
Transcript
Play full episode
